Author Topic: Study shows LDN changes levels of inflammatory proteins in MS  (Read 51 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8218
  • MS diagnosed 1980
  • Location: Pacific Northwest
Study shows LDN changes levels of inflammatory proteins in MS
« on: February 20, 2018, 02:35:13 pm »
LDN is seldom in the news but this is a report on a study showing some possible benefits from taking it for MS. From Multiple Sclerosis News Today, February 20, "Low-dose naltrexone changes levels of inflammatory proteins in MS, study shows":


https://multiplesclerosisnewstoday.com/2018/02/20/low-dose-naltrexone-changes-levels-inflammatory-proteins-in-ms/?utm_source=Multiple+Sclerosis&utm_campaign=3ad0d2cee2-RSS_US_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_b5fb7a3dae-3ad0d2cee2-71286581
MS Speaks--online for 13 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
1 Replies
1230 Views
Last post June 09, 2016, 08:57:33 pm
by agate
0 Replies
45 Views
Last post April 29, 2018, 04:13:33 pm
by agate
0 Replies
10 Views
Last post March 17, 2019, 11:18:38 am
by agate
0 Replies
10 Views
Last post April 19, 2019, 02:37:42 pm
by agate
0 Replies
1 Views
Last post September 14, 2019, 06:56:51 pm
by agate